Rising Pancreatic Adenocarcinoma and Type 2 Diabetes Mellitus-Related Mortality in the United States, 2000 to 2024, With Forecasts to 2034

Mortality from concurrent pancreatic adenocarcinoma and T2DM has risen, with marked disparities by sex, race, age, and region, and the projected increase underscores the need for targeted prevention and early detection in high-risk diabetic populations.